The prognosis of breast cancer patients in relation to the oestrogen receptor status of both primary disease and involved nodes
1992

Breast Cancer Prognosis and Oestrogen Receptor Status

Sample size: 74 publication Evidence: moderate

Author Information

Author(s): L. Castagnetta, A. Traina, G. Carruba, E. Fecarotta, G. Palazzotto, R. Leake

Primary Institution: University School of Medicine, Policlinico, Palermo, Italy

Hypothesis

Does the oestrogen receptor status of involved nodes provide prognostic information for breast cancer patients?

Conclusion

Patients with oestrogen receptor positive nodes have a significantly longer survival than those with negative nodes.

Supporting Evidence

  • Patients with uniformly receptor positive primary tumors had a significant survival advantage.
  • Patients with ER+ nodes survived significantly longer than those with ER- nodes.
  • The study included 74 consecutive breast cancer patients with involved axillary nodes.

Takeaway

This study found that knowing the hormone receptor status of breast cancer can help doctors decide how to treat patients better.

Methodology

The study analyzed oestrogen receptor status in primary tumors and involved nodes of 74 breast cancer patients.

Potential Biases

There is a potential bias as the (+ +) group was slightly older than the (- -) group.

Limitations

The study may have bias due to differences in age among patient groups.

Participant Demographics

Patients included both premenopausal and postmenopausal women with node-positive breast cancer.

Statistical Information

P-Value

p<0.008

Statistical Significance

p<0.003

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication